10x Genomics (NASDAQ:TXG) Issues Earnings Results

10x Genomics (NASDAQ:TXG) posted its quarterly earnings data on Wednesday. The company reported ($0.40) earnings per share for the quarter, missing the consensus estimate of ($0.32) by ($0.08), Zacks reports. 10x Genomics had a negative return on equity of 25.07% and a negative net margin of 28.93%. 10x Genomics updated its FY 2025 guidance to EPS.

10x Genomics Stock Performance

Shares of 10x Genomics stock traded up $0.97 during midday trading on Friday, hitting $12.91. 1,251,023 shares of the company traded hands, compared to its average volume of 2,408,836. The firm’s fifty day moving average price is $14.75 and its 200-day moving average price is $17.43. The stock has a market cap of $1.56 billion, a price-to-earnings ratio of -8.47 and a beta of 1.85. 10x Genomics has a 12 month low of $10.80 and a 12 month high of $51.22.

Analysts Set New Price Targets

A number of research firms recently commented on TXG. Leerink Partnrs lowered shares of 10x Genomics from a “strong-buy” rating to a “hold” rating in a research report on Thursday. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of 10x Genomics in a report on Saturday, February 1st. Canaccord Genuity Group cut their price target on 10x Genomics from $20.00 to $18.00 and set a “buy” rating for the company in a research note on Thursday. Stifel Nicolaus reduced their price target on 10x Genomics from $21.00 to $18.00 and set a “buy” rating on the stock in a research report on Thursday. Finally, JPMorgan Chase & Co. dropped their price objective on 10x Genomics from $14.00 to $12.00 and set a “neutral” rating for the company in a report on Thursday. One research analyst has rated the stock with a sell rating, nine have issued a hold rating and seven have given a buy rating to the company. According to MarketBeat, 10x Genomics presently has an average rating of “Hold” and an average target price of $20.57.

About 10x Genomics

10x Genomics, Inc, a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in the America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium, chromium connect, and chromium controller instruments, microfluidic chips, slides, reagents, and other consumables products.